Chemoradiotherapy versus short-course radiotherapy for response-adapted organ preservation in early-stage and intermediate-stage rectal cancer (STAR-TREC): 12-month results of an international, multicentre, open-label, parallel-group, randomised, phase 2/3 trial.

Bach SP, Sebag-Montefiore D, Homer V, Gilbert A, Appelt A, Geh I, Beets GL, Burger J, Angenete E, Baatrup G, Spindler KG, Haustermans K, Holman F, Kerkhof EM, Lam E, Korsgen S, Martling A, Wolthuis A, Al-Najami I, Lind P, Peters FP, Teo M, West NP, Gates S, Marijnen CAM, de Wilt JHW, STAR-TREC Collaborative

Open source

DOI: 10.1016/s1470-2045(26)00228-7
Published: 2026 Sep
Container: The Lancet. Oncology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s1470-2045-26-00228-7,
  title = {Chemoradiotherapy versus short-course radiotherapy for response-adapted organ preservation in early-stage and intermediate-stage rectal cancer (STAR-TREC): 12-month results of an international, multicentre, open-label, parallel-group, randomised, phase 2/3 trial.},
  author = {Bach SP and Sebag-Montefiore D and Homer V and Gilbert A and Appelt A and Geh I and Beets GL and Burger J and Angenete E and Baatrup G and Spindler KG and Haustermans K and Holman F and Kerkhof EM and Lam E and Korsgen S and Martling A and Wolthuis A and Al-Najami I and Lind P and Peters FP and Teo M and West NP and Gates S and Marijnen CAM and de Wilt JHW and STAR-TREC Collaborative},
  year = {2026},
  journal = {The Lancet. Oncology},
  doi = {10.1016/s1470-2045(26)00228-7},
  url = {https://doi.org/10.1016/s1470-2045(26)00228-7}
}

RIS

TY  - JOUR
TI  - Chemoradiotherapy versus short-course radiotherapy for response-adapted organ preservation in early-stage and intermediate-stage rectal cancer (STAR-TREC): 12-month results of an international, multicentre, open-label, parallel-group, randomised, phase 2/3 trial.
AU  - Bach SP
AU  - Sebag-Montefiore D
AU  - Homer V
AU  - Gilbert A
AU  - Appelt A
AU  - Geh I
AU  - Beets GL
AU  - Burger J
AU  - Angenete E
AU  - Baatrup G
AU  - Spindler KG
AU  - Haustermans K
AU  - Holman F
AU  - Kerkhof EM
AU  - Lam E
AU  - Korsgen S
AU  - Martling A
AU  - Wolthuis A
AU  - Al-Najami I
AU  - Lind P
AU  - Peters FP
AU  - Teo M
AU  - West NP
AU  - Gates S
AU  - Marijnen CAM
AU  - de Wilt JHW
AU  - STAR-TREC Collaborative
PY  - 2026
JO  - The Lancet. Oncology
DO  - 10.1016/s1470-2045(26)00228-7
UR  - https://doi.org/10.1016/s1470-2045(26)00228-7
ER  -

APA

SP, B., D, S., V, H., A, G., A, A., I, G., GL, B., J, B., E, A., G, B., KG, S., K, H., F, H., EM, K., E, L., S, K., A, M., A, W., I, A., P, L., FP, P., M, T., NP, W., S, G., CAM, M., JHW, D. W., & Collaborative, S. (2026). Chemoradiotherapy versus short-course radiotherapy for response-adapted organ preservation in early-stage and intermediate-stage rectal cancer (STAR-TREC): 12-month results of an international, multicentre, open-label, parallel-group, randomised, phase 2/3 trial.. The Lancet. Oncology. https://doi.org/10.1016/s1470-2045(26)00228-7

Source records

pubmed · retrieved 2026-09-25T21:06:56.437Z